Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the U.S. Food and Drug Administration (FDA) has approved VYLOY™ (zolbetuximab-clzb) in combination ...
Telix is in a strong financial position with net cash of AUD 119 million as of June 2024. We forecast free cash flow averaging 82% of net income over the next 10 years, and in the absence of major ...
Still, a case of vitamin toxicity – also known as hypervitaminosis – is rare. You’d have to take very large doses to be at risk. Don’t take more than 1,000mg of vitamin C, 100mcg of vitamin D, 35mg of ...